Session » Orthopedics, Low Back Pain, & Rehabilitation – ACR/ARP Poster

Date: Sunday, November 17, 2024

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2024

10:30AM-12:30PM: Abstract Number: 1182

Assessing Male Pelvic Floor Contractions Using a Novel External Pressure Device and Ultrasound

10:30AM-12:30PM: Abstract Number: 1178

Can Immersive Virtual Reality Improve the Effect of Meditation for People with Fibromyalgia?

10:30AM-12:30PM: Abstract Number: 1179

Development of an Optimal Physiotherapy Intervention to Reduce Stiffness Following Knee Joint Replacement

10:30AM-12:30PM: Abstract Number: 1171

Differences in Microbiome Profiles Based on Pain Severity and Inflammatory Biomarkers in Acute Low Back Pain

10:30AM-12:30PM: Abstract Number: 1181

Disparities in Rehabilitation Outcomes After Knee Arthroplasty

10:30AM-12:30PM: Abstract Number: 1174

Effects of Electroacupuncture on Pain and Joint Deformity in Rat Models of Knee Osteoarthritis: A Study on the Differences in Acupoints Used

10:30AM-12:30PM: Abstract Number: 1176

Exploration of Heterogeneity of Treatment Effects Across Exercise-Based Interventions for Knee Osteoarthritis

10:30AM-12:30PM: Abstract Number: 1172

Participation in Baseball/Softball Associates with Increased Risk for Knee Pain and Osteoarthritis as an Adult: Data from the Osteoarthritis Initiative

10:30AM-12:30PM: Abstract Number: 1175

Physical Activity and Symmetry Following Total Knee Arthroplasty:Results of an Exploratory Trial

10:30AM-12:30PM: Abstract Number: 1180

Relationship Between Changes in Physical Activity and Early Onset Knee Osteoarthritis in Individuals After ACL Reconstruction

10:30AM-12:30PM: Abstract Number: 1173

Safety of Non-Exercise Rehabilitation Interventions for Adults with Rheumatoid Arthritis

10:30AM-12:30PM: Abstract Number: 1177

Supporting Implementation of Group Physical Therapy for Knee Osteoarthritis: Results of a Multisite Implementation Trial

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].